Merger Announced
Clywedog Therapeutics and Barinthus Biotherapeutics merger
Advisers
Barinthus Biotherapeutics
Target
- Financial adviser
- Legal adviser
- Fairness opinion
Acquirer
- Financial adviser
- Target
- Barinthus Biotherapeutics
- Target based in
- United Kingdom
- Sector
- Biotech
Similar deals
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Lisata Therapeutics acquisition of Marea Therapeutics Sep 2026 · Biotech
- North Immunology and Aethlon Medical merger Sep 2026 · Biotech
- Xenetic Biosciences acquisition of Santersus AG Sep 2026 · Medtech
- Leyden Labs acquisition of RIGImmune Sep 2026 · Biotech
Sources
- 30 Apr 2026 Definitive merger proxy statement (DEFM14A), Barinthus Biotherapeutics plc. sec.gov